(secondQuint)Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome.

 Two hundred women at risk of ovarian hyperstimulation syndrome during ICSI cycles will be randomly scheduled into two equal groups.

 In group A, (Diosmin group), 2 tab / 8 hs Diosmin ( 500mg) will be given at day of HCG injection and for 2 weeks ; while in group B (Cabergoline group), 1 tab/day Cabergoline( 0.

5 mg) will be given at day of HCG injection and for eight days.

.

 Diosmin Versus Cabergoline for Prevention of Ovarian Hyperstimulation Syndrome@highlight

The purpose of this study is to compare the effect of oral Diosmin to oral Cabergoline in the prevention of ovarian hyperstimulation syndrome (OHSS) in high-risk women underwent intracytoplasmic sperm injection (ICSI).

